May 5, 2024 Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool
May 5, 2024 Opportunities and Challenges for Cost-Efficient Implementation of New Point-of-Care Diagnostics for HIV and Tuberculosis
May 5, 2024 Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform
May 5, 2024 Eliminating Tuberculosis and Tuberculosis-HIV Co-Disease in the 21st Century: Key Perspectives, Controversies, Unresolved Issues, and Needs
May 5, 2024 Drug-Resistant Tuberculosis–Current Dilemmas, Unanswered Questions, Challenges, and Priority Needs
May 5, 2024 The Predictive Safety Testing Consortium: Safety Biomarkers, Collaboration, and Qualification